Mini tumors in a dish could pick the right drug for Hard-to-Treat cancers

NCT ID NCT05267912

Ongoing Knowledge-focused Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 14 times

Summary

This study explores whether growing a patient's tumor cells into tiny 3D organoids in the lab can help doctors choose the most effective treatment. It includes 152 adults with advanced solid cancers that have stopped responding to standard therapies. Researchers will test different drugs on the organoids to see which ones work best, then compare that to how the patient actually responds.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED, PRETREATED SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Centre Eugène Marquis

Rennes, France, 35000, France
Centre Léon Bérard

Lyon, France, 69008, France
Centre Oscar Lambret

Lille, France, 59000, France
Gustave Roussy

Villejuif, 94805, France
Hôpital Pitié-Salpêtrière

Paris, France, 75013, France
Hôpital Saint Louis

Paris, France, 75010, France
Institut Bergonié

Bordeaux, France, 33000, France
Institut Godinot

Reims, France, 51726, France

Conditions

Explore the condition pages connected to this study.

ADVANCED, PRETREATED SOLID TUMORS